Clinical Trial

Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital

Study acronym: TOXO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 23, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
Toxoplasmosis in HIV-positive individuals is well-studied and has a codified management protocol, which is not the case for other immunodeficiencies, except for recent recommendations in the context of hematopoietic stem cell transplantation. A description of this population is necessary to estimate the number of patients affected and to define their specific management (diagnosis, treatment, prevention).
Trial Details
NCT Number NCT07299500
Lead Sponsor University Hospital, Strasbourg, France
Conditions Cerebral Toxoplasmosis
Enrollment 30 participants
Start Date 2025-02-02
Primary Completion 2026-02 (estimated)
Study Completion 2026-02-25 (estimated)
Updated on ClinicalTrials.gov 2025-12-23